Recent Company News

• 04:37 AM ET Jul 02, 2026
  

  Hutchmed receives NMPA conditional approval for ORPATHYS for treatment of gastric caner with MET amplification (HK$17.60, 0.00)

• 08:20 PM ET Jun 24, 2026
  

  Hutchmed to announce results from pivotal Phase II registration study of fanregratinib in ICC at at ESMO 2026 (HK$16.20, 0.00)

• 12:01 AM ET Jun 18, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (294 total)

• 10:01 AM ET Jun 17, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (123 total)

• 03:37 AM ET Jun 17, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (66 total)

• 12:17 AM ET Jun 17, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (198 total)

• 03:45 AM ET Jun 16, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (39 total)

• 11:20 PM ET Jun 15, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (123 total)

• 11:45 PM ET Jun 09, 2026
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (161 total)

• 10:07 AM ET Jun 09, 2026
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (254 total)